(Automated translation by Reuters, please see disclaimer * Nike withdraws its annual revenue forecast * The company expects an 8% to 10% drop in revenue in the second quarter * Nike reports first-quarter earnings per share of 70 cents, compared to estimates of 52 cents (Rewritten to add details of the conference call and context) … Read more
(Automated translation by Reuters, please see disclaimer October 1 – ** Shares of Nike NKE.N rose 0.84% to $89.14 on Tuesday, bucking the market’s slide, ahead of its scheduled quarterly earnings release after the closing bell ** Investors and analysts expect NKE to lower its annual sales forecast in first earnings report since Elliot Hill … Read more
(Automated translation by Reuters, please see disclaimer by Ananya Mariam Rajesh and Nicholas P. Brown Investors and analysts expect Nike NKE.N to lower its annual forecast on Tuesday when it reports quarterly results, the company’s first earnings report since announcing a new chief executive early of the month. Elliott Hill, who spent 32 years at … Read more
Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceutical company developing emergency medicines delivered with its award-winning ZENEO® needle-free auto-injector, announces the appointment of veteran healthcare executive Tony Tipton as Chief Operating Officer, U.S. With over 25 years of experience in key sectors of the commercial pharmaceutical industry, he brings expertise in corporate governance and development, … Read more
((Automated translation by Reuters, please see disclaimer (Added earnings comparison in paragraph 10 and updated stocks) by Ananya Mariam Rajesh On Holding ONON.N beat analysts’ estimates for second-quarter revenue on Tuesday on strong demand for its footwear and apparel from customers looking for fashionable products, but shares fell 9% premarket as the company maintained its … Read more
((Automated translation by Reuters, please see disclaimer (Added details to paragraphs 4 and 5) The U.S. health regulator has refused to approve a therapy based on the psychotropic drug MDMA for patients suffering from post-traumatic stress disorder, saying it could not be approved based on the data submitted, Lykos Therapeutics said Friday. Commonly referred to … Read more
((Automated translation by Reuters, please see disclaimer by Dawn Chmielewski and Greg Bensinger When Mike Hopkins was approached to lead Amazon AMZN.O Prime Video, his vision for the streaming service matched that widely held in Hollywood: It was nothing more than a perk for subscribers to the online retailer’s two-day delivery service. But Amazon founder … Read more
((Automated translation by Reuters, please see disclaimer Servier Pharmaceuticals said Tuesday that the U.S. Food and Drug Administration has approved the French manufacturer’s treatment for a type of brain tumor, making it the first drug to be approved in the United States for the condition. The drug, called voranigo, is used to treat a form … Read more
((Automated translation by Reuters, please see disclaimer by Fanny Potkin and Heekyong Yang Aug. 6 – (A version of Samsung Electronics’ 005930.KS) fifth-generation HBM chips has successfully passed Nvidia NVDA.O’s testing for use in its artificial intelligence (AI) processors, three sources familiar with the results said. The qualification removes a major hurdle for the world’s … Read more
(Automated translation by Reuters, please see disclaimer April 12 – **Shares of engineering services company Argan AGX.N up 22.7% to $60.50 ** Stock hits six-year high ** Company’s Q4 revenue rises 38.5% to $164.55 million vs. $161.60 million forecast – LSEG data ** The increase in turnover is attributable to increased profits from several energy … Read more